Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population

Lupus

Volumn 22, Issue 3, 2013, Pages 268-278

  Furst, D E ^a   Clarke, A ^b   Fernandes, A W ^c   Bancroft, T ^d   Gajria, K ^c   Greth, W ^c   Iorga, S R ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MEDIMMUNE   (United States)

^d OPTUM   (United States)

Author keywords

Costs; resources; retrospective; systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CENTRAL NERVOUS SYSTEM; DATA BASE; DEMOGRAPHY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION FOR NURSING PRACTICE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84874410091     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312474087     Document Type: Article

References (28)

1. Manson JJ, Isenberg DA. The pathogenesis of systemic lupus erythematosus. Neth J Med. 2003 ; 61: 343-346
2. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
3. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
4. Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis. 2006 ; 1: 6-6
5. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002 ; 61: 409-413
6. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003 ; 82: 299-308
7. Urowitz MB, Gladman DD, Abu-Shakra M, Farewell VT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol. 1997 ; 24: 1061-1065
8. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010 ; 39: 257-268
9. McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995 ; 38: 1260-1270
10. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis. 1991 ; 50: 490-492
11. Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum. 1985 ; 28: 80-86
12. Naleway AL, Davis ME, Greenlee RT, Wilson DA, McCarty DJ. Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus. 2005 ; 14: 862-866
13. Uramoto KM, Michet CJ, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999 ; 42: 46-50
14. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization data. Arthritis Rheum. 2007 ; 56: 2092-2094
15. Maskarinec G, Katz AR. Prevalence of systemic lupus erythematosus in Hawaii: Is there a difference between ethnic groups?. Hawaii Med J. 1995 ; 54: 406-409
16. Balluz L, Philen R, Ortega L, et al. Investigation of systemic lupus erythematosus in Nogales, Arizona. Am J Epidemiol. 2001 ; 154: 1029-1036
17. Furst DE, Clarke A, Fernandes AW, Bancroft T, Greth W, Iorga Ş R. Epidemiology of systemic lupus erythematosus in a large United States managed care population. Lupus 2012, in press.
18. Li T, Carls GS, Panopalis P, Wang S, Gibson TB, Goetzel RZ. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: A five-year analysis of a large Medicaid population. Arthritis Rheum. 2009 ; 61: 755-763
19. Panopalis P, Yazdany J, Gillis JZ, et al. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis Rheum. 2008 ; 59: 1788-1795
20. Carls G, Li T, Panopalis P, et al. Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis. J Occup Environ Med. 2009 ; 51: 66-79
21. Yelin E, Trupin L, Katz P, et al. Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus. Arthritis Rheum. 2007 ; 57: 508-515
22. Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database. Clin Ther. 2009 ; 31: 2653-2664
23. Zhu TY, Tam LS, Li EK. Cost of illness studies in systemic lupus erythematosus: A systematic review. Arthritis Care Res (Hoboken). 2011 ; 63: 751-760
24. Chastek BJ, Oleen-Burkey M, Lopez-Bresnahan MV. Medical chart validation of an algorithm for identifying multiple sclerosis relapse in healthcare claims. J Med Econ. 2010 ; 13: 618-625
25. Rector TS, Wickstrom SL, Shah M, et al. Specificity and sensitivity of claims - based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res. 2004 ; 39: 1839-1857
26. Chibnik LB, Massarotti EM, Costenbader KH. Identification and validation of lupus nephritis cases using administrative data. Lupus. 2010 ; 19: 741-743
27. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD - 9-CM and ICD-10 administrative data. Medical Care. 2005 ; 43: 1130-1139
28. Silverman S, Dukes EM, Johnston SS, Brandenburg NA, Sadosky A, Huse DM. The economic burden of fibromyalgia: Comparative analysis with rheumatoid arthritis. Curr Med Res Opin. 2009 ; 25: 829-840